Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MAPLIGHT THERAPEUTICS INC | 950,011 | 950,011 | 0 | $19.31M | $34.05M | 11.83% | +$14.73M |
| Tyra Biosciences, Inc.(TYRA) | 1,029,298 | 1,029,298 | 0 | $39.42M | $32.88M | 11.42% | -$6.55M |
| ENTRADA THERAPEUTICS INC | 4,056,379 | 4,056,379 | 0 | $51.19M | $29.85M | 10.37% | -$21.34M |
| PHARVARIS N V COM | 797,600 | 797,600 | 0 | $22.53M | $27.58M | 9.58% | +$5.05M |
| CAMP4 THERAPEUTICS CORP | 5,869,091 | 5,869,091 | 0 | $25.88M | $25.65M | 8.91% | -$234.8K |
| ARTIVA BIOTHERAPEUTICS INC | 2,353,304 | 2,353,304 | 0 | $15.16M | $22.83M | 7.93% | +$7.67M |
| TECTONIC THERAPEUTIC INC | 606,660 | 606,660 | 0 | $18.75M | $20.85M | 7.24% | +$2.10M |
| ZENTALIS PHARMACEUTICALS INC | 3,947,913 | 3,947,913 | 0 | $9.24M | $19.15M | 6.65% | +$9.91M |
| Celldex Therapeutics, Inc.(CLDX) | 497,270 | 497,270 | 0 | $15.77M | $18.50M | 6.43% | +$2.73M |
| EYEPOINT INC | 1,050,000 | 1,050,000 | 0 | $13.53M | $15.02M | 5.22% | +$1.48M |
| Biohaven Ltd.(BHVN) | 738,972 | 738,972 | 0 | $6.25M | $11.00M | 3.82% | +$4.74M |
| SURROZEN INC | 387,500 | 271,250 | -116,250 | $11.29M | $7.04M | 2.44% | -$4.25M |
| SKYE BIOSCIENCE INC | 9,681,763 | 9,681,763 | 0 | $5.95M | $6.71M | 2.33% | +$762.0K |
| ALX ONCOLOGY HLDGS INC | 3,057,325 | 3,057,325 | 0 | $6.13M | $6.33M | 2.20% | +$198.7K |
| PROTARA THERAPEUTICS INC | 1,369,782 | 1,369,782 | 0 | $7.14M | $5.23M | 1.82% | -$1.90M |
| SILENCE THERAPEUTICS PLC | 476,200 | 476,200 | 0 | $2.51M | $5.23M | 1.82% | +$2.72M |
| CENTESSA PHARMACEUTICALS PLC | 580,945 | 0 | -580,945 | $23.08M | $0 | — | -$23.08M |
| Erasca, Inc.(ERAS) | 3,485,971 | 0 | -3,485,971 | $56.40M | $0 | — | -$56.40M |
| GH Research PLC(GHRS) | 572,665 | 0 | -572,665 | $8.05M | $0 | — | -$8.05M |
| RALLYBIO CORP | 291,788 | 0 | -291,788 | $2.62M | $0 | — | -$2.62M |